Connect with us
Lakeway, NY — (US MARKET BUZZ) — 12/17/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock...
Celgene Corporation (NASDAQ:CELG)’s shares declined 0.84% to $86.05. The company on July 9 announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral,...
Amgen Inc. (NASDAQ:AMGN)’s shares declined 1.78% to $116.86. The company on July 1 announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Amgen Inc. (NASDAQ:AMGN)’s shares declined 0.66% to $118.98. The company on July 1 announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Amgen Inc. (NASDAQ:AMGN)’s shares declined 0.11% to $119.64. The company on July 1 announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Amgen Inc. (NASDAQ:AMGN)’s shares gained 0.69% to $119.77. The company on July 1 announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)’s shares dropped 1.95% to $7.03. The company on July 1 announced that it has been added to the Russell 2000 and Russell...